These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3731104)
21. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929 [TBL] [Abstract][Full Text] [Related]
22. Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancer. Chlebowski RT; Gota CH; Chan KK; Weiner JM; Block JB; Bateman JR Cancer Res; 1982 Nov; 42(11):4827-30. PubMed ID: 7127318 [TBL] [Abstract][Full Text] [Related]
23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
24. Regional perfusion of VX 2 carcinoma with cis-DDP. Aigner KR; Link KH; Woescher H; Johannes W; Hundeiker M Anticancer Res; 1983; 3(6):431-4. PubMed ID: 6686923 [TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288 [TBL] [Abstract][Full Text] [Related]
27. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation. Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128 [TBL] [Abstract][Full Text] [Related]
28. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits. Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343 [TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Kerr IG; Zimm S; Collins JM; O'Neill D; Poplack DG Cancer Res; 1984 Nov; 44(11):4929-32. PubMed ID: 6488155 [TBL] [Abstract][Full Text] [Related]
30. [Distribution of 5-fluorouracil in plasma and pancreatic tissue of rats during the regional arterial infusion chemotherapy]. Tao W; Zhao Y; Cai L; Zhu Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):390-4. PubMed ID: 12567439 [TBL] [Abstract][Full Text] [Related]
31. Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model. Cao S; Lu K; Tóth K; Slocum HK; Shirasaka T; Rustum YM Clin Cancer Res; 1999 Feb; 5(2):267-74. PubMed ID: 10037174 [TBL] [Abstract][Full Text] [Related]
32. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion. Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664 [TBL] [Abstract][Full Text] [Related]
33. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection. Kaneko A; Naomoto Y; Aoyama M; Tanaka N In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178 [TBL] [Abstract][Full Text] [Related]
34. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits. Hawkins MG; Taylor IT; Craigmill AL; Tell LA J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261 [TBL] [Abstract][Full Text] [Related]
35. [Some regularities of the distribution of antitumor preparations during intra-arterial administration]. Gasparian SA Farmakol Toksikol; 1968; 31(1):87-91. PubMed ID: 4970781 [No Abstract] [Full Text] [Related]
36. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs. Smith DE; Brenner DE; Knutsen CA; Deremer SJ; Terrio PA; Johnson NJ; Stetson PL; Ensminger WD Drug Metab Dispos; 1993; 21(2):277-83. PubMed ID: 8097697 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits. Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910 [TBL] [Abstract][Full Text] [Related]
38. High-dose 5-fluorouracil with delayed uridine "rescue" in mice. Martin DS; Stolfi RL; Sawyer RC; Spiegelman S; Young CW Cancer Res; 1982 Oct; 42(10):3964-70. PubMed ID: 7104997 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes]. Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402 [TBL] [Abstract][Full Text] [Related]
40. Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview. Håkansson L; Håkansson A; Morales O; Thorelius L; Warfving T Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-100-S6-109. PubMed ID: 9151924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]